ESPE2015 Poster Category 3 Diabetes (94 abstracts)
Fanconi-Bickel Syndrome due to a Novel SLC2A2 Mutation Presenting with Transient Neonatal Diabetes
Selin Elmaogullari a , Fatma Demirel a, , Derya Tepe a , Nida Dincel c , Meltem Tayfun a , Seyit Ahmet Ucakturk a , Fatih Gurbuz a & Houghton Jayne d
aAnkara Children’s Hematology and Oncology Training Hospital Ankara Children’s Hematology and Oncology Training Hospital Pediatric Endocrinology Clinic, Ankara, Turkey; bYildirim Beyazit U. School of Medicine, Pediatric Endocrinology Clinic, Ankara, Turkey; cAnkara Children’s Hematology and Oncology Training Hospital Ankara Children’s Hematology and Oncology Training Hospital Pediatric Nephrology Clinic, Ankara, Turkey; dExeter U. School of Medicene, Molecular Genetics Laboratory, Exeter, UK
Background: Fanconi-Bickel syndrome (FBS) is a glycogen storage disease caused by the homozygous mutations of SLC2A2 gene which codes GLUT2 protein. It is characterized by growth retardation, hepatomegaly and hypophosphataemic rickets. While most of the cases with FBS have fasting hypoglycaemia and postprandial hyperglycaemia, only few cases had been shown to have neonatal diabetes (ND).
Case presentation: A 14 days old girl was admitted to hospital with difficulty in feeding. She was born 2620 g from consanguineous parents. She had hyperglycemia (bloodsugar: 651 mg/dl) and metabolic acidosis (blood pH: 7.1 HCO3: 11); intravenous fluid and insulin treatment were started with diagnosis of ND. She had increased parenchymal echogenicity in renal ultrasonography but her renal functional tests (RFT), serum and spot urine electrolytes were normal and she did not have proteinuria. She was discharged with subcutaneus NPH insülin. At the age of four months insülin was discontinued and ramipril was started because of newly diagnosed proteinuria. Molecular genetic study showed her homozygous for a novel missense mutation (p.A127D, c.380C>A) in SLC2A2 gene. Her parents were heterozygous for that mutation. When she was evaluated for FBS findings in addition to present growth failure and proteinuria at nine months of age; RFT and serum electrolytes were normal but tubular phosphate reabsorption was decreased. Unlike increased renal echogenicity compatible with diffuse parenchymal disease, there wasn’t liver involvement in abdominal ultrasonography.
Conclusion: ND can be the initial finding of FBS. After excluding frequent causes, FBS should be kept in mind for differential diagnosis for ND. Cases with homozygous SLC2A2 mutations should be followed for growth retardation, hepatomegaly and hypophosphataemic rickets.
Article tools
My recent searches
My recently viewed abstracts
Authors
ESPE Abstracts
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more